Enroxil
|
100 mg/ml
|
V/NRP/96/0301
|
KRKA, d.d., Novo mesto, Slovēnija
|
QJ01MA90
|
turkeys; chickens
|
Vairāk
|
Medicinal product information
Products
ID |
Strength |
Package size |
Primary packaging |
Labelling |
V/NRP/96/0301-01 |
100 mg/ml |
1 |
Stikla pudelīte (brūna), 100 ml |
[JPG]
[JPG]
[JPG]
[JPG]
|
V/NRP/96/0301-02 |
100 mg/ml |
1 |
Stikla pudelīte (brūna), 1 l |
[JPG]
[PDF]
[JPG]
|
|
Enroxil
|
100 mg/ml
|
V/NRP/95/0194
|
KRKA, d.d., Novo mesto, Slovēnija
|
QJ01MA90
|
cattle; pigs
|
Vairāk
|
Medicinal product information
Products
ID |
Strength |
Package size |
Primary packaging |
Labelling |
V/NRP/95/0194-01 |
100 mg/ml |
1 |
Stikla pudelīte (brūna), 50 ml |
[JPG]
[JPG]
|
V/NRP/95/0194-02 |
100 mg/ml |
1 |
Stikla pudelīte (brūna), 100 ml |
[PDF]
[PDF]
[PDF]
[PDF]
|
|
Enroxil
|
50 mg/ml
|
V/NRP/95/0195
|
KRKA, d.d., Novo mesto, Slovēnija
|
QJ01MA90
|
cattle; pigs; sheep; goats; dogs; calves
|
Vairāk
|
Medicinal product information
Products
ID |
Strength |
Package size |
Primary packaging |
Labelling |
V/NRP/95/0195-01 |
50 mg/ml |
1 |
Stikla pudelīte (brūna), 50 ml |
[JPG]
[JPG]
|
V/NRP/95/0195-02 |
50 mg/ml |
1 |
Stikla pudelīte (brūna), 100 ml |
[PDF]
[PDF]
[PDF]
|
|
Enroxil Flavour
|
15 mg
|
V/DCP/08/1617
|
KRKA, d.d., Novo mesto, Slovēnija
|
QJ01MA90
|
dogs; cats
|
Vairāk
|
Medicinal product information
Pharmaceutical form: |
tablets
|
International name (active substance): |
Enrofloxacin
|
Distribution category: |
To be supplied only on veterinary prescription
|
Manufacturer(s) responsible for batch release |
KRKA, d.d., Novo mesto, Slovēnija
|
Date of authorisation/renewal: |
27-Feb-2014
|
Marketing authorisation valid until: |
Unlimited time period
|
Marketing authorisation procedure: |
DCP
|
Package leaflet: |
[DOC] 230321LI (23-Mar-2021)
|
Labelling text: |
[DOC] 230321M (23-Mar-2021)
|
Summary of product characteristics: |
[DOCX] 230321ZA (23-Mar-2021)
|
Products
ID |
Strength |
Package size |
Primary packaging |
Labelling |
V/DCP/08/1617-01 |
15 mg |
100 |
Blisteris, 1 tablete |
[PDF]
[JPG]
|
V/DCP/08/1617-02 |
15 mg |
10 |
Blisteris, 1 tablete |
[PDF]
|
|
Enroxil Flavour
|
50 mg
|
V/DCP/08/1618
|
KRKA, d.d., Novo mesto, Slovēnija
|
QJ01MA90
|
dogs
|
Vairāk
|
Medicinal product information
Pharmaceutical form: |
tablets
|
International name (active substance): |
Enrofloxacin
|
Distribution category: |
To be supplied only on veterinary prescription
|
Manufacturer(s) responsible for batch release |
KRKA, d.d., Novo mesto, Slovēnija
|
Date of authorisation/renewal: |
27-Feb-2014
|
Marketing authorisation valid until: |
Unlimited time period
|
Marketing authorisation procedure: |
DCP
|
Package leaflet: |
[DOCX] 230321LI (23-Mar-2021)
|
Labelling text: |
[DOC] 230321M (23-Mar-2021)
|
Summary of product characteristics: |
[DOCX] 230321ZA (23-Mar-2021)
|
Products
ID |
Strength |
Package size |
Primary packaging |
Labelling |
V/DCP/08/1618-01 |
50 mg |
100 |
Blisteris, 1 tablete |
[PDF]
[JPG]
|
V/DCP/08/1618-02 |
50 mg |
10 |
Blisteris, 1 tablete |
[PDF]
|
|
Enroxil Flavour
|
150 mg
|
V/DCP/08/1619
|
KRKA, d.d., Novo mesto, Slovēnija
|
QJ01MA90
|
dogs
|
Vairāk
|
Medicinal product information
Pharmaceutical form: |
tablets
|
International name (active substance): |
Enrofloxacin
|
Distribution category: |
To be supplied only on veterinary prescription
|
Manufacturer(s) responsible for batch release |
KRKA, d.d., Novo mesto, Slovēnija
|
Date of authorisation/renewal: |
27-Feb-2014
|
Marketing authorisation valid until: |
Unlimited time period
|
Marketing authorisation procedure: |
DCP
|
Package leaflet: |
[DOC] 230321LI (23-Mar-2021)
|
Labelling text: |
[DOC] 230321M (23-Mar-2021)
|
Summary of product characteristics: |
[DOC] 230321ZA (23-Mar-2021)
|
Products
ID |
Strength |
Package size |
Primary packaging |
Labelling |
V/DCP/08/1619-01 |
150 mg |
100 |
Blisteris, 1 tablete |
[PDF]
[JPG]
|
V/DCP/08/1619-02 |
150 mg |
10 |
Blisteris, 1 tablete |
[PDF]
|
|